Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Leukemia

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2013.321PMID 24170028PMCID PMC5875430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

  2013cited by this paper
• Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling

  2013cited by this paper
• Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.

  2012cited by this paper
• Comparison of nerve growth factor receptor binding models using heterodimeric muteins

  2012cited by this paper
• G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

  2011cited by this paper
• Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.

  2010cited by this paper
• Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805

  2010cited by this paper
• Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

  2010cited by this paper
• Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.

  2010cited by this paper
• G-CSF stimulates Jak2-dependent Gab2 phosphorylation leading to Erk1/2 activation and cell proliferation.

  2008cited by this paper
• Ex Vivo‐Expanded Bone Marrow CD34+ Derived Neutrophils Have Limited Bactericidal Ability

  2008cited by this paper
• Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.

  2007cited by this paper
• Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders.

  2007cited by this paper
• Suppressor of cytokine signaling 3 controls lysosomal routing of G‐CSF receptor

  2007cited by this paper
• Multiple pathways contribute to the hyperproliferative responses from truncated granulocyte colony-stimulating factor receptors

  2006cited by this paper
• Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor

  2006cited by this paper
• An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia

  2005cited by this paper
• Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics.

  2004cited by this paper
• G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.

  2004cited by this paper
• G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.

  2004cited by this paper
• Loss of SHIP and CIS Recruitment to the Granulocyte Colony-Stimulating Factor Receptor Contribute to Hyperproliferative Responses in Severe Congenital Neutropenia/Acute Myelogenous Leukemia1

  2004cited by this paper
• Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells.

  2003cited by this paper
• Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells.

  2002cited by this paper
• Regulation of granulopoiesis by transcription factors and cytokine signals

  2000cited by this paper
• Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform.

  2000cited by this paper
• Defective Internalization and Sustained Activation of Truncated Granulocyte Colony-Stimulating Factor Receptor Found in Severe Congenital Neutropenia/Acute Myeloid Leukemia

  1999cited by this paper
• Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells*

  1999cited by this paper
• Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia–derived Mutation in the G-CSF Receptor Gene

  1999cited by this paper
• Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia.

  1999cited by this paper
• Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.

  1999cited by this paper
• Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia

  1998cited by this paper
• The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand.

  1997cited by this paper
• Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival.

  1997cited by this paper
• Molecular Characterization of Specific Interactions between SHP-2 Phosphatase and JAK Tyrosine Kinases*

  1997cited by this paper
• Tissue-specific Pattern of Stress Kinase Activation in Ischemic/Reperfused Heart and Kidney*

  1997cited by this paper
• Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia

  1997cited by this paper
• Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia

  1997cited by this paper
• Preparation of an Iodinated Radioligand

  1997cited by this paper
• Dimerization of the extracellular domain of granuloycte-colony stimulating factor receptor by ligand binding: a monovalent ligand induces 2:2 complexes.

  1996cited by this paper
• Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.

  1995cited by this paper
• Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.

  1994cited by this paper
• Signal transduction mediated by growth hormone receptor and its chimeric molecules with the granulocyte colony-stimulating factor receptor.

  1993cited by this paper
• Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor.

  1993cited by this paper
• Three different mRNAs encoding human granulocyte colony-stimulating factor receptor.

  1990cited by this paper
• Expression cloning of a receptor for murine granulocyte colony-stimulating factor.

  1990cited by this paper
• Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells

  1985cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper

• Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia

  2025cites this paper
• Neutrophils: a new target for postoperative cognitive dysfunction

  2025cites this paper
• Expanding the Spectrum of CSF3R-Mutated Myeloid Neoplasm Beyond Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia: A Comprehensive Analysis of 13 Cases

  2025cites this paper
• Multiomics Integration and Machine Learning Reveal Colony Stimulating Factor 3 Receptor as a Key Gene and Therapeutic Target in Crohn's Disease

  2025cites this paper
• G-CSF in feline medicine: From molecular mechanisms to clinical applications.

  2025cites this paper
• Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology

  2024cites this paper
• Old drug, new use: Recent advances for G-CSF.

  2024cites this paper
• Breast tumor metastasis following filgrastim administration due to the SDF-1/CXCR4 pathway

  2023cites this paper
• JAK/STAT: Why choose a classical or an alternative pathway when you can have both?

  2022cites this paper
• A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer

  2022cites this paper
• Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms

  2022cites this paper
• G-CSF, the guardian of granulopoiesis.

  2021cites this paper
• New insight into the mechanism of granulocyte colony-stimulating factor (G-CSF) that induces the mobilization of neutrophils

  2021cites this paper
• Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation, without eliciting an unfolded protein response

  2020cites this paper
• Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer

  2020cites this paper
• Donor CSF3R with the rs3917980A/G or G/G genotype is correlated with better leukemia-free survival after allogenic hematopoietic stem cell transplantation

  2020cites this paper
• T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.

  2019cites this paper
• Therapy of acute myeloid leukemia: therapeutic targeting of tyrosine kinases

  2019cites this paper
• Naturally occurring and synthetic constitutive-active cytokine receptors in disease and therapy.

  2019cites this paper
• Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations

  2019cites this paper
• Cytokine receptor splice variants in hematologic diseases.

  2019cites this paper
• Inherited Neutropenias and Their Insights into Cellular and Developmental Biology

  2018cites this paper
• We skip to work: alternative splicing in normal and malignant myelopoiesis

  2018cites this paper
• Genomic Instability in Severe Congenital Neutropenia, a Leukemia Predisposition Syndrome

  2018cites this paper
• Splicing dysfunction and disease: The case of granulopoiesis.

  2017cites this paper
• The ba/f3 transformation assay: characterization of a novel csf2rb-activating variant, and the discovery of acquired mutations in ba/f3 cells

  2017influential citation
• A t(1;9) translocation involving CSF3R as a novel mechanism in unclassifiable chronic myeloproliferative neoplasm

  2017cites this paper
• Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations

  2017cites this paper
• G-CSF and GM-CSF in Neutropenia

  2015cites this paper
• The cell survival pathways of the primordial RNA-DNA complex remain conserved in the extant genomes and may function as proto-oncogenes.

  2015cites this paper
• Is Associated with the Leukemogenic Potential of the Class IV Granulocyte Colony-Stimulating Factor Receptor in CD 34 + Progenitor Cells

  2015cites this paper
• Systems approach to phagocyte production and activation: neutrophils and monocytes.

  2014cites this paper
• miR-155 Is Associated with the Leukemogenic Potential of the Class IV Granulocyte Colony-Stimulating Factor Receptor in CD34+ Progenitor Cells

  2014cites this paper